Express Scripts Holding Company (NASDAQ:ESRX) has been given an average recommendation of “Hold” by the twenty-six ratings firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $68.95.
ESRX has been the topic of a number of recent research reports. BidaskClub cut Express Scripts Holding from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Needham & Company LLC initiated coverage on Express Scripts Holding in a report on Friday, July 21st. They set a “hold” rating on the stock. Morgan Stanley increased their price objective on Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a report on Thursday, August 10th. Jefferies Group LLC set a $72.00 price objective on Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. Finally, Robert W. Baird reissued a “hold” rating and set a $56.00 price objective on shares of Express Scripts Holding in a report on Friday, September 1st.
In other news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now directly owns 11,500 shares in the company, valued at approximately $735,195. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Everett Neville sold 1,163 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the transaction, the vice president now owns 18,232 shares in the company, valued at $1,120,903.36. The disclosure for this sale can be found here. Insiders have sold a total of 5,641 shares of company stock worth $357,317 over the last quarter. Corporate insiders own 0.68% of the company’s stock.
Several institutional investors have recently made changes to their positions in ESRX. Burt Wealth Advisors grew its position in Express Scripts Holding by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after acquiring an additional 174 shares during the last quarter. CKW Financial Group grew its position in Express Scripts Holding by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after acquiring an additional 300 shares during the last quarter. TrimTabs Asset Management LLC bought a new position in Express Scripts Holding during the 1st quarter worth approximately $121,000. IHT Wealth Management LLC grew its position in Express Scripts Holding by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after acquiring an additional 145 shares during the last quarter. Finally, First Personal Financial Services grew its position in Express Scripts Holding by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after acquiring an additional 1,400 shares during the last quarter. Hedge funds and other institutional investors own 88.69% of the company’s stock.
Express Scripts Holding (ESRX) traded up 0.70% during midday trading on Thursday, hitting $57.21. The stock had a trading volume of 3,405,612 shares. The company has a 50-day moving average price of $61.90 and a 200-day moving average price of $62.41. Express Scripts Holding has a 52 week low of $56.62 and a 52 week high of $77.50. The stock has a market cap of $33.04 billion, a P/E ratio of 9.93 and a beta of 0.88.
Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.57 EPS. Equities analysts expect that Express Scripts Holding will post $6.99 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This article was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2017/10/26/express-scripts-holding-company-esrx-receives-69-34-consensus-pt-from-brokerages.html.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.